"ORTO Klīnika ir vienīgā privātā traumatoloģijas, ortopēdijas un mugurkaula ķirurģijas klīnika Baltijā, kas specializējas: - locītavu saslimšanu diagnostikā un ārstēšanā – tai skaitā reimatoloģisku saslimšanu ārstēšanā; - muguras problēmu risināšanā un ķirurģiskā ārstēšanā; - traumu dziedēšanā; - sporta medicīnā; - rehabilitācijas nodrošināšanā pēc ķirurģiskas iejaukšanās; - fizioterapijas pakalpojumu sniegšanā."

During the past decade, ORTO clinic Ltd conducted 4 clinical trials. In the 10-year time frame, 4 clinical trials started and 3 clinical trials were completed, i.e. on average, 75% percent of trials that started reached the finish line to date. In the past 5 years, 2 clinical trials started and 2 clinical trials were completed. i.e. 100% of trials that started reached the finish line.

According to Clinical.Site data, the most researched conditions in "ORTO clinic Ltd" are "Arthritis, Psoriatic" (2 trials), "Rhematoid Arthritis" (1 trials), "Traumatic Articular Cartilage Defects in the Knee Joint" (1 trials) and "Venous Thromboembolism" (1 trials). Many other conditions were trialed in "ORTO clinic Ltd" in a lesser frequency.

Most popular intervention types in "ORTO clinic Ltd" are "Drug" (5 trials), "Biological" (2 trials) and "Procedure" (1 trials). Other intervention types were less common.

The name of intervention was led by "Guselkumab" (2 trials), "Placebo" (2 trials), "Adalimumab with methotrexate" (1 trials), "Enoxaparin" (1 trials) and "Microfracture" (1 trials). Other intervention names were less common.

The vast majority of trials in "ORTO clinic Ltd" are 5 trials for "All" genders.

Currently, there are NaN active trials in "ORTO clinic Ltd". undefined are not yet recruiting, 1 are recruiting, 1 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 3 completed trials in ORTO clinic Ltd, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in ORTO clinic Ltd, 0 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 3 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 0 trials that are defined as “Not Applicable".